News / Business
Abbott India Limited (BOM:500488) to Release Q1 2009 Earnings March 28
Abbot India Limited (BOM:50488) will release the first quarter earnings for 2009 on Friday, March 28.
Abbot India Limited, a healthcare company, is involved in the discovery, development, manufacture and marketing of pharmaceutical, diagnostic, nutritional and hospital products. The company offers healthcare solutions through its four primary business segments.
Primary Care is involved in the marketing of pain management and gastroenterology products under the Brufen, Digene, Cremaffin and Norvir brand names.
Specialty Care Methabolics and Urology offers diabetes, thyroid disorders, obesity and benign prostatic hyperplasia solutions.
Specialty Care-Neuroscience consists of specialty products in neurology and psychiatric segments.
Abbot India Limited (BOM:50488) hospital care provides products for the anesthesiology and neonatology fields.
For more Earnings related events or to post your own events, visit:
